Now a retired pharmacovigilance expert, Dr Auclert trained in clinical pharmacology and pharmaco-epidemiology after obtaining his MD in Paris. He started his career in the pharmaceutical industry in 1985, working in clinical development (clinical trials phase I to IV) for three companies (SK&F, Rhone-Poulenc, Hoechst-Roussel). In 1995, he moved into pharmacovigilance, joining AstraZeneca where he started as head of the French pharmacovigilance unit. From 2010 until his retirement in 2014, he was the QPPV of the Sanofi group. He chaired the EFPIA pharmacovigilance committee from 2012 to 2014.